Antigenic Expression of B-Cell Chronic Lymphocytic Leukemic Cell Lines

References

• Marti G. E., Fleisher T. A. B cell CLL Immunophenotypes. Chronic Lymphocyli Leukemia: Recent Progress and Future Direction, R. P. Gale, K. Rai. Alan R. Liss, Inc. 1987; 195–204
   Google Scholar
• Marti G. E., Fleisher T. A. Application of lymphocyte immunophenotyping in selected diseases. Path and Immunopath Res. 1988; 7(5)345–356
   PubMedGoogle Scholar
• Marti G. E., Zenger V., Caproaso N. E., Brown M., Washington G. C., Carter P., Schecter G., Noguchi P. Antigenic expression of B-cell chronic lymphocytic leukemia lymphocytes. Analytical and Quantitative Cytology and Histology 1989; 11(5)315–323
   PubMed Web of Science ®Google Scholar
• Hurley J. N., Fu S. M., Kunkel G. G., McKenna G., ScharfT M. D. Lymphoblastoid cell lines from patients with chronic lymphocytic leukemia: Identification of tumor origin idiotypic analysis. Proc. Nat. Acad. Sci. 1978; 75(11)5706–5710
   PubMed Web of Science ®Google Scholar
• Crescenzi M., Napolitano M., Carbonari M., Antonelli A., Petronelli P., Gaetano C., Fiorilli M. Establishment of a new Epstein-Barr virus immortalized cell line from chronic lymphocytic leukemia with trisomy of chromosome 12 that produces monoclonal IgM against a sheep RBC antigen. Blood 1988; 71(1)9–12
   PubMed Web of Science ®Google Scholar
• Melo J. V., Brito-Babapulle V., Foroni L., Robinson D. S. F., Luzzatto L., Catovsky D. Two new cell lines from B-prolymphocytic leukaemia: characterization by morphology, immunological markers, karyotype and Ig gene rearrangement. Int. J. Cancer 1986; 38: 531–538
   PubMed Web of Science ®Google Scholar
• Flow cytometry analysis of the B-cell blind panel: joint report. Leucocyte Typing IV White Cell Differentiation, W. Knapp, B. Dorken, W. R. Gilks, E. P. Reiber, R. E. Schmidt, H. Stein, A. E. G. Kr. published by Oxford Univeristy Press. 1989; 165–174
   Google Scholar
• Wilkinson Leland. SYSTAT: The System for Statistics. SYSTAT, Inc., Evanston, III 1987
   Google Scholar
• Freedman A. S., Boyd A. W., Bieber F. R., Daley J., Rosen K., Horowitz J. C., Levy D. N., Nadler L. M. Normal cellular counterparts of B cell chronic lymphocytic leukemia. Blood 1987; 70: 418–427
   PubMed Web of Science ®Google Scholar
• Freedman A. S., Nadler L. M. B cell development in chronic lymphocytic leukemia. Semin. Hematol 1987; 24: 230–239
   PubMed Web of Science ®Google Scholar
• Vogt R. F., Marti G. E., Schwartz A. Quantitative Calibration of Fluorochrome Intensity for Clinical and Research Applications of Leucocyte Immunophenotyping by Flow Cytometry. Critical Issues in Biotechnology and Bioengineering. Ablex Publishing Co., Norwood, New Jersey
   Google Scholar
• Oonishi T., Uyesaka N. A new standard fluoresein microsphere for quantitative flow cytometry. J Immunol Methods 1985; 84: 251–256
   PubMed Web of Science ®Google Scholar
• Hebell T., Ahearn J. M., Fearon D. T. Supression of the Immune Response by a Soluble Complement Receptor of B Lymphocytes. Science 1991; 254: 102–105
   PubMed Web of Science ®Google Scholar
• Nardi F., Kudo J., Mars W., Calabretta B., Florine D. L., Barlogie B., Saunders G. F. HLA-DR-associated invariant chain is highly expressed in chronic lymphocytic leukemia. Blood 1986; 68(2)372–7
   PubMed Web of Science ®Google Scholar
• Marti G. E., Faguet G., Bertin P., Agee J., Washington G., Ruiz S., Carter P., Zenger V., Vogt R., Nogushi P. CD20 and CDS Expression in B-Chronic Lymphocytic Leukemia (B-CLL). Prod. NY Acad. Sci. 1992, in press
   Google Scholar
• Fauget G. B., Agee J. F., Marti G. E. CD5 and cCLLa expression in chronic lymphocytic leukemia (CLL); Demonstration of their relative prevalence and that of other common B-CLL markers. Leukemia and Lymphoma. 1992
   Google Scholar
• Geisler C. H., Larsen J. K., Hansen N. E., Hansen, Christensen M. M., Lund B., Nielsen H., Plesner T., Thorling K., Andersen E., Andersen P. K. Prognostic Importance of Flow Cytometric Immunophenotyping of 540 Consecutive Patients With B-Cell chronic Lymphocytic Leukemia. Blood 1991; 78(7)1795–1802
   PubMed Web of Science ®Google Scholar
• Lnghirami G., Nakamura M., Balow J. E., Noktins A. L., Casali P. Model for Studying Virus Attachment: Identification and Quantitation of EBV-Binding Cells Using Biotinylated Virus in Flow Cytometry. J. Virol 1988; 62(7)2453–2463
   PubMed Web of Science ®Google Scholar
• Kawamura N., Muraguchi A., Hori A., Horii Y., Mutsuura S., Hardy R. R., Kikutani H., Kishimoto T. A case of human B cell leukemia that implicates an autocrine mechanism in the abnormal growth of Leu 1 B cells. J. Clin. Invest. 1986; 78: 1331–1338
   PubMed Web of Science ®Google Scholar
• Levitt M. L., Barry W. E., Helfrich M. K., Kaiser-McCaw B., Henderson E. E. Characterization of Epstein-Barr virus carrying cell lines established from chronic lymphocytic leukemia. Cancer Research 1983; 43: 1195–1203
   PubMed Web of Science ®Google Scholar
• Najfeld V., Fialkow P. J., Karande A., Nilsson K., Klein G., Penfold G. Cancer Res. 1980; 43: 1195–1203
   Google Scholar
• Karande A., Fialkow P. J., Nilsson K., Klein G., Najfeld V., Penfold G. Establishment of a lymphoid cell line from leukemic cells of a patient with chronic lymphocytic leukemia. Int. J. Cancer 1980; 26: 551–556
   Google Scholar
• Melo J. V., Foroni L., Brito-Babapulle V., Luzzatto L., Catovsky D. The establishment of cell lines from chronic B cell leukemias: evidence of leukemic origin by karyotypic abnormalities and IG gene rearrangement. Clin. Exp. Immunol 1988; 73(1)23–8
   PubMed Web of Science ®Google Scholar
• Johnstone A. P. Chronic lymphocytic leukaemia and its relationship to normal B lymphopoieses. Immunology Today 1982; 13(12)343–348
   Google Scholar
• Rickinson A. B., Finerty S., Epstein M. A. Interaction of Epstein-Barr virus with leukaemic B cells in vitro. I. Abortive infection and rare cell line establishment from chronic lymphocytic leukaemic cells. Clin. Exp. Immunol. 1982; 50: 347–354
   PubMed Web of Science ®Google Scholar
• Chan M. A., Stein L. D., Dosch H., Sigal N. H. Heterogeneity of EBV-transformable human B lymphocyte populations. J Immunol. 1986; 136(1)106–112
   PubMed Web of Science ®Google Scholar
• Tosato G., Blaese R. M. Epstein-Barr virus infection and immunoregulation in man. Adv. Immunol. 1985; 37: 99–149
   PubMed Web of Science ®Google Scholar
• Tosato G. The Epstein-Barr virus and the immune system. Adv. Cancer Res. 1987; 49: 75–125
   PubMed Web of Science ®Google Scholar
• Tatsumi E., Harada S., Bechtold T., Lipscomb H., Davis J., Kuszynski C., Volsky D. J., Armitage J., Purtilo D. T. In vitro infection of chronic lymphocytic leukemia cells by Epstein-Barr virus (EBV). Leukemia 1986; 10: 167–177
   Web of Science ®Google Scholar
• Justement L. B., Campbell K. S., Shien N. C., Cambier J. C. Regulation of B Cell Antigen Receptor Signal Transduction and Phosphorylation by CD45. Science 1991; 252: 1839–1842
   PubMed Web of Science ®Google Scholar